Search

Search Constraints

You searched for: Author/Creator Mocci, G

Search Results

1. P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab. (25th January 2019)

2. P810 Clinical features of ulcerative colitis patients in Sardinia, Italy – First results from a multi-centre study. (25th January 2019)

3. P783 Long-term colectomy rate in acute severe ulcerative colitis. An observational multi-centre study on behalf of IG-IBD (Italian group for the study of inflammatory bowel disease). (25th January 2019)

4. P541 Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study. (25th January 2019)

6. P613 Predictors of treatment persistence in ulcerative colitis patients treated with golimumab: A multicentre cohort study. (16th January 2018)

7. P527 Telemedicine in IBD patients: results of a national survey of the Italian IBD patients' association (AMICI Onlus). (21st January 2022)

8. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors. (21st January 2022)

9. P463 COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey of the Italian IBD patients' association (AMICI Onlus). (27th May 2021)

10. P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study. (27th May 2021)